Cannabis use and mental health-related quality of life among individuals with depressive disorders

Psychiatry Research

Volumn 230, Issue 2, 2015, Pages 341-349

  Aspis, Itay ^a   Feingold, Daniel ^b,c,d   Weiser, Mark ^a,c   Rehm, Jurgen ^e,f,g   Shoval, Gal ^a,h   Lev Ran, Shaul ^a,b,e  

^a TEL AVIV UNIVERSITY   (Israel)

^b Sheba   (Israel)

^c SHEBA MEDICAL CENTER   (Israel)

^d ARIEL UNIVERSITY   (Israel)

^e CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^f UNIVERSITY OF TORONTO   (Canada)

^g DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^h GEHA MENTAL HEALTH CENTER   (Israel)

Author keywords

Cannabis; Depressive disorders; Dysthymia; Major depressive disorder; Quality of Life

Indexed keywords

ADULT; AGED; ARTICLE; CANNABIS USE; CONTROLLED STUDY; DEPRESSION; EMOTION; FEMALE; FUNCTIONAL STATUS; GENDER; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH; PATIENT CODING; PRIORITY JOURNAL; QUALITY OF LIFE; SAMPLE SIZE; SHORT FORM 12; ADOLESCENT; CANNABIS ADDICTION; MIDDLE AGED; PSYCHOLOGICAL RATING SCALE; PSYCHOLOGY; QUESTIONNAIRE; YOUNG ADULT;

CANNABIS;

ADOLESCENT; ADULT; AGED; CANNABIS; DEPRESSIVE DISORDER; FEMALE; HUMANS; MALE; MARIJUANA ABUSE; MENTAL HEALTH; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; QUALITY OF LIFE; SURVEYS AND QUESTIONNAIRES; YOUNG ADULT;

EID: 84942064006     PISSN: 01651781     EISSN: 18727123     Source Type: Journal    
DOI: 10.1016/j.psychres.2015.09.014     Document Type: Article

References (40)

1. Bovasso G.B. Cannabis abuse as a risk factor for depressive symptoms. Am. J. Psychiatry 2001, 158(12):2033-2037.
2. Brady K.T., Randall C.L. Gender differences in substance use disorders. Psychiatr. Clin N. Am. 1999, 22(2):241-252.
3. Brook D.W., Brook J.S., Zhang C., Cohen P., Whiteman M. Drug use and the risk of major depressive disorder, alcohol dependence, and substance use disorders. Arch. Gen. Psychiatry 2002, 59(11):1039-1044.
4. Buckner J.D., Keough M.E., Schmidt N.B. Problematic alcohol and cannabis use among young adults: the roles of depression and discomfort and distress tolerance. Addict. Behav. 2007, 32(9):1957-1963.
5. Cao Y., Li W., Shen J., Zhang Y. [Association between health related quality of life and severity of depression in patients with major depressive disorder]. Zhong Nan Da Xue Xue Bao Yi Xue Ban 2011, 36(2):143-148.
6. Chen C.Y., Wagner F.A., Anthony J.C. Marijuana use and the risk of major depressive episode. Epidemiological evidence from the United States National Comorbidity Survey. Soc. Psychiatry Psychiatr. Epidemiol. 2002, 37(5):199-206.
7. Compton W.M., Grant B.F., Colliver J.D., Glantz M.D., Stinson F.S. Prevalence of marijuana use disorders in the United States: 1991-1992 and 2001-2002. J. Am. Med. Assoc. 2004, 291(17):2114-2121.
8. Degenhardt L., Coffey C., Romaniuk H., Swift W., Carlin J.B., Hall W.D., Patton G.C. The persistence of the association between adolescent cannabis use and common mental disorders into young adulthood. Addiction 2013, 108(1):124-133.
9. Degenhardt L., Hall W. Extent of illicit drug use and dependence, and their contribution to the global burden of disease. Lancet 2012, 379(9810):55-70.
10. Degenhardt L., Lynskey M., Hall W. Cohort trends in the age of initiation of drug use in Australia. Aust. N. Z. J. Public Health 2000, 24(4):421-426.
11. Fattore L., Fratta W. How important are sex differences in cannabinoid action?. Br. J. Pharmacol. 2010, 160(3):544-548.
12. Fazel S., Bains P., Doll H. Substance abuse and dependence in prisoners: a systematic review. Addiction 2006, 101(2):181-191.
13. Feingold.D., Weiser M., Rehm J., Lev-Ran S. The association between cannabis use and mood disorders: a longitudinal study. J. Affect. Disord. 2015, 172:211-218.
14. Fergusson D.M., Boden J.M. Cannabis use and later life outcomes. Addiction 2008, 103(6):969-976. discussion 977-968.
15. Fergusson D.M., Horwood L.J. Early onset cannabis use and psychosocial adjustment in young adults. Addiction 1997, 92(3):279-296.
16. Fergusson D.M., Horwood L.J., Swain-Campbell N. Cannabis use and psychosocial adjustment in adolescence and young adulthood. Addiction 2002, 97(9):1123-1135.
17. Gonzalez-Saiz F., Rojas O.L., Castillo I.I. Measuring the impact of psychoactive substance on health-related quality of life: an update. Curr. Drug Abuse Rev. 2009, 2(1):5-10.
18. Grant B.F., Dawson D.A., Stinson F.S., Chou P.S., Kay W., Pickering R. The Alcohol Use Disorder and Associated Disabilities Interview Schedule-IV (AUDADIS-IV): reliability of alcohol consumption, tobacco use, family history of depression and psychiatric diagnostic modules in a general population sample. Drug Alcohol. Depend 2003, 71(1):7-16.
19. Grant B.F., Stinson F.S., Dawson D.A., Chou S.P., Dufour M.C., Compton W., Pickering R.P., Kaplan K. Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Arch. Gen. Psychiatry 2004, 61(8):807-816.
20. Grucza R.A., Abbacchi A.M., Przybeck T.R., Gfroerer J.C. Discrepancies in estimates of prevalence and correlates of substance use and disorders between two national surveys. Addiction 2007, 102(4):623-629.
21. Hall W., Degenhardt L. Adverse health effects of non-medical cannabis use. Lancet 2009, 374(9698):1383-1391.
22. Hill M.N., Gorzalka B.B. The endocannabinoid system and the treatment of mood and anxiety disorders. CNS Neurol. Disord. Drug Targets 2009, 8(6):451-458.
23. Huang B., Grant B.F., Dawson D.A., Stinson F.S., Chou S.P., Saha T.D., Goldstein R.B., Smith S.M., Ruan W.J., Pickering R.P. Race-ethnicity and the prevalence and co-occurrence of Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, alcohol and drug use disorders and Axis I and II disorders: United States, 2001 to 2002. Compr Psychiatry 2006, 47(4):252-257.
24. Kessler R.C., Chiu W.T., Demler O., Merikangas K.R., Walters E.E. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch. Gen. Psychiatry 2005, 62(6):617-627.
25. Le Foll B., Gorelick D.A., Goldberg S.R. The future of endocannabinoid-oriented clinical research after CB1 antagonists. Psychopharmacology (Berl) 2009, 205(1):171-174.
26. Lev-Ran S., Imtiaz S., Taylor B.J., Shield K.D., Rehm J., Le Foll B. Gender differences in health-related quality of life among cannabis users: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Drug Alcohol Depend 2012, 123(1-3):190-200.
27. Lev-Ran S., Le Foll B., McKenzie K., George T.P., Rehm J. Cannabis use and cannabis use disorders among individuals with mental illness. Compr. Psychiatry 2013, 54(6):589-598.
28. Lev-Ran S., Le Foll B., McKenzie K., Rehm J. Cannabis use and mental health-related quality of life among individuals with anxiety disorders. J. Anxiety Disord. 2012, 26(8):799-810.
29. Lev-Ran S., Roerecke M., Le Foll B., George T.P., McKenzie K., Rehm J. The association between cannabis use and depression: a systematic review and meta-analysis of longitudinal studies. Psychol. Med. 2013, 1-14.
30. Lev-Ran S., Roerecke M., Le Foll B., George T.P., McKenzie K., Rehm J. The association between cannabis use and depression: a systematic review and meta-analysis of longitudinal studies. Psychol. Med. 2014, 44(4):797-810.
31. Lynskey M.T., Heath A.C., Bucholz K.K., Slutske W.S., Madden P.A., Nelson E.C., Statham D.J., Martin N.G. Escalation of drug use in early-onset cannabis users vs co-twin controls. J. Am. Med. Assoc. 2003, 289(4):427-433.
32. Moore T.H., Zammit S., Lingford-Hughes A., Barnes T.R., Jones P.B., Burke M., Lewis G. Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. Lancet 2007, 370(9584):319-328.
33. Najavits L.M., Lester K.M. Gender differences in cocaine dependence. Drug Alcohol. Depend 2008, 97(1-2):190-194.
34. Nicholson W.K., Setse R., Hill-Briggs F., Cooper L.A., Strobino D., Powe N.R. Depressive symptoms and health-related quality of life in early pregnancy. Obstet Gynecol. 2006, 107(4):798-806.
35. Patton G.C., Coffey C., Carlin J.B., Degenhardt L., Lynskey M., Hall W. Cannabis use and mental health in young people: cohort study. Br. Med. J. 2002, 325(7374):1195-1198.
36. Regier D.A., Kaelber C.T., Rae D.S., Farmer M.E., Knauper B., Kessler R.C., Norquist G.S. Limitations of diagnostic criteria and assessment instruments for mental disorders. Implications for research and policy. Arch. Gen. Psychiatry 1998, 55(2):109-115.
37. Schwilke E.W., Gullberg R.G., Darwin W.D., Chiang C.N., Cadet J.L., Gorelick D.A., Pope H.G., Huestis M.A. Differentiating new cannabis use from residual urinary cannabinoid excretion in chronic, daily cannabis users. Addiction 2011, 106(3):499-506.
38. Turner-Bowker D.M.B.P., Ware J.E. SF-36 Health Survey and SF Bibliography 2002, Quality Metric Inc., Lincoln, RI. 3rd ed.
39. Ware J., Kosinski M., Keller S.D. A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med. Care 1996, 34(3):220-233.
40. World Health Organization The World Health Organization Quality of Life assessment (WHOQOL): position paper from the World Health Organization. Soc. Sci. Med. 1995, 41(10):1403-1409.